Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen

Table 3

Results of anti-VEGF therapy in nAMD including RAP.

	AMD with drusen (n = 64)	AMD without drusen (n = 84)
Change, mean (SD)
VA (logMAR)	0.14 (0.61)	0.04 (0.45)	0.69
CRT (μm)	94.3 (108.6)	104.8 (210.4)	0.98
SFCT (μm)	41.3 (65.3)	46.3 (68.6)	0.54
Number of injection (no./yr), mean (SD)	4.8 (3.7)	4.7 (3.1)	0.78